- £1.58bn
- £2.11bn
- GEL2.64bn
- 30
- 90
- 72
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 802 | 835 | 1,003 | 1,290 | 1,636 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 710 | 484 | 1,032 | 1,158 | 1,457 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 586 | 319 | 921 | 1,247 | 1,334 |
Provision for Income Taxes | |||||
Net Income After Taxes | 540 | 322 | 809 | 1,003 | 1,140 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 538 | 318 | 801 | 995 | 1,124 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 538 | 318 | 801 | 995 | 1,124 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.73 | 6.24 | 14.5 | 17.9 | 20.6 |
Dividends per Share |